Macrophage Therapeutics Development Service
Overview Service Portfolios Related Products Service Features Scientific Resources Q & A

As a heterogeneous population of immune cells, macrophages provide crucial innate immune defense and play several and diverse functions in homeostatic and immune responses. Creative Biolabs combines deep, industry-leading expertise with innovative platforms to provide a full range of high-quality services to support macrophage therapeutics development. With an experienced team of in-house experts, we have developed a consultative strategy to provide our clients with a highly customizable solution. Our scientists are pleased to share our advanced technology and extensive expertise in macrophage therapeutics development.

Overview of Macrophage Therapeutics

macrophage-therapeutics-development-service

Featured by remarkable plasticity, macrophages change their physiology in response to various environmental stimuli. They can be classified into two extremes: a pro-inflammatory (M1) and an anti-inflammatory/pro-resolving (M2) profile. M1 population occur after exposure to microbial antigens and are able to start and sustain inflammatory responses, secret pro-inflammatory cytokines, such as interferon-γ (IFN-γ), activate endothelial cells, and recruit other immune cells into the inflamed tissue. On the other hand, M2 macrophages promote the resolution of inflammation, phagocytose apoptotic cells, drive collagen deposition, coordinate tissue integrity, and release anti-inflammatory mediators. These specialized cells have an enhanced cytotoxic phenotype and play central roles in a wide range of diseases, such as cancers, autoimmune diseases, cardiovascular diseases, and tuberculosis.

Therapeutic Applications of Macrophages

Application Areas Macrophage Therapeutics Technology and Innovation
Cancer Immunotherapy Tumor-associated macrophages (TAM): Strategies to repolarize TAM to an M1 phenotype include:
  • Checkpoint inhibitors: Target PD-1/PD-L1 or CD47-SIRPα signaling to enhance macrophage phagocytosis.
  • Small molecules and cytokines: Use of agents such as TLR agonists or IFN-γ to activate the M1 pathway.
Advances in technology have paved the way for customized macrophage therapies.
  • CRISPR/Cas9
  • Synthetic biology
  • Nanoparticles
  • Biomimetic particles
  • Single-cell transcriptomics
  • Proteomics and metabolomics
Cell therapy: Macrophages modified to express chimeric antigen receptors (CAR-M) therapies are capable of precisely targeting and destroying tumor cells while modulating the tumor microenvironment.
Autoimmune Diseases Treatment aims to shift the balance towards M2 macrophages to reduce inflammation and promote tissue repair.
Nanoparticle-based delivery: Targeting immunomodulators to macrophages increases precision and minimizes systemic side effects.
Infectious Diseases Innovative therapies aim to enhance macrophage antimicrobial activity while mitigating chronic inflammation.
Regenerative Medicine Tissue engineering and repair: Strategies to harness M2 macrophages include:
  • Scaffold-based approaches: Incorporating macrophage-recruiting cytokines into biomaterials.
  • Exosome therapy: Utilizing macrophage-derived exosomes to deliver growth factors like VEGF for angiogenesis.
  • Cardiac and neural repair

Service Portfolios for Macrophage Therapeutics Development at Creative Biolabs

Creative Biolabs is a well-recognized leader in the field of immuno-oncology. Equipped with a team of seasoned scientists with facilities designed specifically to meet every challenging requirement in macrophage therapeutics development, we offer fast, reliable support for any phase of macrophage therapeutics development. Based on our advanced macrophage therapeutics development platform, our scientists provide a comprehensive portfolio including macrophage isolation and culture service, macrophage polarization assay, macrophage polarization phenotype identification and characterization service, macrophage reprogramming service, macrophage-targeted drug delivery system development, macrophage engineering service for drug delivery, and macrophage marker development service.

Highlights

  • Polarization phenotype can be identified with unique characteristics.
  • Characterization of each macrophage population may help to explain disease aetiologies.
  • Reprogramming tumor-associated Macrophage (TAM) by different strategies.
  • Engineering macrophage for therapeutics delivery.
  • The identification of markers may allow us to delete specific populations of macrophages, or for diagnostic purposes.

Scientists at Creative Biolabs are versed in macrophage therapeutics development. We are glad to serve our global clients with professionalism and expertise. Our comprehensive portfolio provides reliable support to help our clients' macrophage therapeutics development projects. For more detailed information, please feel free to contact us or send us your inquiry or question.

Related Products

Creative Biolabs designs and develops a range of useful products to assist customers in macrophage therapy development, cell therapy research and disease modeling. Our comprehensive portfolio includes monocytes, macrophages, culture reagents, differentiation reagents, assay kits, viral vectors, and other related products that contribute to our customers' research.

In the table below, we have provided some popular products that you can click to view the details.

Cat.No Product Name Product Type
MTS-0922-JF10 Human Macrophages, Alveolar Human Macrophages
MTS-0922-JF99 Human M0 Macrophages, 1.5 x 10^6 Human M0 Macrophages
MTS-0922-JF52 C57/129 Mouse Macrophages, Bone Marrow C57/129 Mouse Macrophages
MTS-0922-JF7 Human M2 Macrophages, Peripheral Blood, 10 x 10^6 Human M2 Macrophages
MTS-0922-JF34 CD1 Mouse Macrophages CD1 Mouse Macrophages
MTS-1022-JF91 Mouse Bone Marrow Monocytes (with Cas9 Expression), 0.5 x 10^6 cells Immune cells
MTS-1022-JF1 B129 Mouse Bone Marrow Monocytes, 1 x 10^7 cells Immune cells
MTS-1022-JF10 Human PB CD14+ Monocytes (Age: 23), 5 x 10^7 cells Immune cells
MTS-1022-JF5 CD1 Mouse Bone Marrow Monocytes, 1 x 10^7 cells Immune cells
MTS-1022-JF4 Canine Bone Marrow Monocytes, 5 x 10^6 cells Immune cells
MTS-1123-HM7 Macrophage Colony Stimulating Factor (MCSF) ELISA Kit, Fluorometric ELISA Kit
MTS-1123-HM11 Monocyte To Macrophage Differentiation Associated Protein (MMA) ELISA Kit, Colorimetric ELISA Kit
MTS-1123-HM9 Macrophage Expressed Gene 1 (MPEG1) ELISA Kit, Colorimetric ELISA Kit
MTS-1123-HM15 Macrophage Chemokine Ligand 19 (CCL19) ELISA Kit, qPCR ELISA Kit
MTS-1123-HM50 Macrophage Migration Inhibitory Factor (MIF) Competition ELISA Kit ELISA Kit

Service Features

Comprehensive Phenotypic Characterization and Profiling

Our advanced phenotypic polarization analysis provides an in-depth analysis of macrophage phenotypes. Utilizing cutting-edge flow cytometry, transcriptomics and proteomics platforms, scRNA-seq and high-dimensional imaging technologies to precisely define macrophage polarization status.

Powerful Preclinical Evaluation System

We use advanced 3D culture systems and organoids to model physiologically relevant microenvironments to provide more predictive data on treatment effects. Our platform provides validated animal models for a variety of disease indications, ensuring the generation of reliable preclinical data.

Service Features

Custom Engineered Platforms

We have expertise in designing transgenic macrophages and macrophages as delivery vehicles for targeted therapies, including customized genetic engineering approaches, customized vector system approaches.

High-Throughput Screening (HTS) Capabilities

We offer HTS platforms to identify small molecules, antibodies or biologics that modulate macrophage activity. Our genome-wide screening capabilities enable us to identify novel macrophage-specific genes or pathways.

Scientific Resources

Q & A

Q: What sample types can you work with for macrophage research?
A: We are able to work with a wide range of sample types for macrophage-related studies, including primary cells isolated from human, mouse, or rat tissues, as well as immortalized macrophage cell lines. Our team has extensive experience handling and processing various sample types to ensure the integrity of your macrophage samples throughout the research workflow.

Q: Can you help me with custom macrophage-related assay development?
A: Absolutely. We understand that your research may require specialized or unique macrophage-related assays. Our team of experts is well-versed in assay development and optimization, and we would be happy to work closely with you to design and validate custom macrophage assays tailored to your specific research objectives. We can provide guidance on experimental parameters, analytical techniques, and data interpretation to ensure the success of your custom assay project.

Q: Can you provide macrophage samples from different disease models or conditions?
A: Yes, we have access to a broad range of macrophage samples from various disease models and pathological conditions. This includes samples from models of inflammation, infection, cancer, metabolic disorders, and more. Our extensive products allow us to provide you with well-characterized macrophage samples that can help you investigate the role of these cells in the context of your specific research interests.

Q: How long does it usually take to complete a macrophage-related research project?
A: Project timelines depend on the complexity of your research needs. For basic assays such as cytokine analysis, we can provide results in a short period of time. More complex services, such as custom macrophage model development or gene editing, may take longer. We always work closely with our clients to provide realistic timelines and progress updates throughout the project.

Online Inquiry
  •  

CONTACT US
(USA)
(UK)
(Germany)
ADDRESS

> Global

ISO 9001 Certified - Creative Biolabs Quality Management System.

Copyright © 2025 Creative Biolabs. All Rights Reserved.